AI in Medicine Archives

AI in Healthcare: The Hype, The Reality, and The Promise

by A. Karim Kader, MD, PhD | Aug 2024

A. Karim Kader, MD, PhD, FRCSC, explores the current state and future potential of artificial intelligence (AI) in healthcare. Dr. Kader begins by analyzing AI’s role in transforming current medical practice.
Dr. Kader acknowledges AI’s benefits, including its potential to revolutionize diagnostics, treatment planning, and patient care. When acting as a “scribe,” AI can be invaluable in creating grant proposals, patient education materials, and the writing of operative notes.
Looking ahead, Dr. Kader envisions a future where AI is seamlessly integrated into routine clinical practice, augmenting the capabilities of healthcare professionals and enhancing patient care. He calls for continued investment in AI research, interdisciplinary collaboration, and the development of robust frameworks for AI implementation and governance.

Interviews with Icons: Paul Perito, MD, FACS

by Neil H. Baum, MD | Aug 2024

Grand Rounds in Urology Contributing Editor Neil H. Baum, MD, engages with Paul Perito, MD, FACS, a leading expert in urology. Considered by urologists as the Prince of Prosthetics, Dr. Perito is the leading penile implanter in the world. He has trained hundreds of urologists in his minimally invasive technique, which has streamlined the procedure and reduced implantation time to less than 20 minutes.

APC Pathways – The Large Urology Group Practice Model

by Jeffrey M. Spier, MD and Travis Mendel, MD | Aug 2024

Jeffrey M. Spier, MD, and Travis Mendel, MD, discuss the use of Advanced Prostate Cancer (APC) Pathways within large urology group practices. Dr. Spier begins by reviewing the impact of oral options and other advances in treatment collaboration between APC patients and their physicians which led to the formation of large urology group practices.

Dr. Spier then discusses the factors which contribute to the success of large urology groups in treating patients with APC, with an emphasis on improved quality of care. He highlights the importance of combining real-world clinical intelligence with a multidisciplinary approach for continuous improvement in the quality of care received by patients.

Dr. Mendel takes over from Dr. Spier by explaining the differences between clinical guidelines and clinical pathways. He presents examples of treatment pathways for various stages of APC, with a focus on the impact of PSMA-PET.

Dr. Mendel concludes by discussing the potential use of these pathways in creating better AI treatment aids for physicians. Dr. Spier ends the presentation with an emphasis on the positive impact of a multidisciplinary team.

Interviews with Icons: Alan Wein, MD, PhD, FACS

by Neil H. Baum, MD | May 2024

Grand Rounds in Urology Contributing Editor Neil H. Baum, MD, interviews Alan Wein, MD, PhD, FACS, on the past, present, and future of overactive bladder treatment in Urology. Among his many achievements, Dr. Wein has co-written or co-edited +30 books on Urology, including several editions of the textbook, Campbell Walsh Wein Urology, and holds editorial board positions on 14 journals. Additionally, Dr. Wein is largely credited as the researcher who lead the charge to rename “unstable bladder” to overactive bladder.

In this interview, they discuss Dr. Wein’s perspective on:
The History of Overactive Bladder
The Role of Pharmacology in Lower Urinary Tract Dysfunction
The Evolution of Incontinence and Overactive Bladder Treatments
The Role of AI and Telemedicine in Treatment
The Future of Urinary Incontinence and Overactive Bladder Management